HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention - Wikidata - awgldk - TriplyDB

HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention

HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention

http://www.wikidata.org/entity/Q34957142

about

Drug-induced reactivation of apoptosis abrogates HIV-1 infection Activation of the DNA Damage Response by RNA Viruses Cellular and viral determinants of retroviral nuclear entry Virological Mechanisms in the Coinfection between HIV and HCV Yeast and the AIDS virus: the odd couple Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders The HIV-1 protein Vpr impairs phagosome maturation by controlling microtubule-dependent trafficking HIV virions as nanoscopic test tubes for probing oligomerization of the integrase enzyme.R77Q and Q3R HIV1-VPR mutations in an otherwise asymptomatic 5-year-old child with repeated ear infections Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences Short communication: circulating plasma HIV-1 viral protein R in dual HIV-1/tuberculosis infection The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr.The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.Peptides that inhibit HIV-1 integrase by blocking its protein-protein interactions.The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization.HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis.Converging strategies in expression of human complex retroviruses Large Isoform of Mammalian Relative of DnaJ is a Major Determinant of Human Susceptibility to HIV-1 Infection.HIV-1, reactive oxygen species, and vascular complications The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.Host restriction factors in retroviral infection: promises in virus-host interaction.Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex Substance abuse, HIV-1 and hepatitis Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1.Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development 14-3-3s are potential biomarkers for HIV-related neurodegeneration.HIV-1 Vpr N-terminal tagging affects alternative splicing of the viral genome.YWHAE/14-3-3ε: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment.The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors.Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr).Sensing of HIV-1 Infection in Tzm-bl Cells with Reconstituted Expression of STING.

P2860

Q21090718-9135F796-56B9-474A-AAEF-39ADDB20661C Q26769967-70D3A940-6B16-42D3-B400-71F864B5B46A Q26778299-ACE8D1B4-CF1A-4620-ADA5-5654B400C7BB Q26780313-35C04DBA-8915-429A-A6B7-5B766EB66AFC Q26852313-96C273DF-A41D-4625-B650-D32A0FBA78BA Q27025573-25399D00-66A4-4EAD-B629-9A1A92234548 Q27309574-7D15D205-545F-44CA-A1E2-5B60EA348733 Q30407372-CD9BCEEA-6600-48BF-9457-0E15B91D92C0 Q33635218-50BAA99E-CE2F-4C27-8220-E757152EAA38 Q33768060-708F3AA8-83C4-41FE-A2B8-5BC4FF0EA5F8 Q33828287-CED8A504-C77A-48BA-88C3-C6F800EC99FB Q34020546-384CD32B-4910-4003-B12E-B3F2DCD82F3B Q34106660-5B400B09-20B6-4988-B42F-D265E228DA31 Q34220186-EE0E8AF9-6B73-48C1-A6DA-302877741844 Q34267043-7BD1B9ED-4304-40B2-92DF-78A168FEA2B4 Q34320018-03782A15-27F9-4239-85BE-FF3A4E26368D Q34712821-770AF8E9-53C5-4B64-B07D-EFA1E5663474 Q34758051-A303D2CA-D727-4608-BFF3-92F45FB85EB6 Q34848256-81361D14-433A-439B-9B78-4F0B68CEC094 Q35261679-D0DBBD26-F737-4C36-A2F2-03AD79E42483 Q35688192-2EB65C5B-10C3-48E2-B3C6-37CBDE8C27CA Q36040759-598C4DD4-D68F-4E02-9DE4-E05D9A928FDF Q36104509-5CE5C656-B2B6-4888-A480-1C461EA7C5E0 Q36376632-D9C521EA-E58A-47FD-BE1E-1A09E0065DE5 Q36484010-C7D8E42F-0C0F-465C-8B05-7C4D82F45F92 Q36548179-B3E2DA08-DAAE-444C-9CBC-D32CCC409F32 Q36706005-358B7BB5-2023-4B16-85CC-B00E9EF59D5E Q36890536-47BF60BE-405B-4FCF-A5DE-D6599A30532A Q37003023-529E108E-2AAB-4B2A-B9A9-2B2054FA159F Q37114645-1F5794FD-E181-4B4A-A106-4364C93DDF65 Q37127522-4DA75634-B8F9-4FB5-8AFE-1FC19D1DEDE2 Q37149637-342872FC-CF78-4B69-8329-509668399BBE Q37323917-3220D20F-0828-4EB0-B90E-D0A9632EC697 Q37657002-EE7BF1D3-BFB8-4065-8603-0068BBB8AFA5 Q37959034-6832C201-8ACB-4F54-A300-5ED9585493CE Q38162985-5DEFE024-CBF4-42BC-8767-CD0A7B845238 Q38524164-F037AAB7-CE25-46C1-8DD4-6454247456A6 Q38628801-93A384DA-5EB8-40BB-94F2-33D7462A1AC3 Q38761101-7CC57F58-9935-4951-BFD0-85EA2D89B620 Q38812549-20F3F7E1-77FA-4158-88B6-48C236AD2BF1

P2860

HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention

http://www.wikidata.org/entity/Q34957142

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@ast

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@en

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@nl

type

label

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@ast

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@en

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@nl

prefLabel

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@ast

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@en

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@nl

P1433

Q34957142-965CAC5E-473C-461A-B77F-2FE65F12B32C

P1476

Q34957142-57E8ADBC-28FA-4109-8D79-AE227EE66879

P2093

Q34957142-6DB6B077-AA85-4624-AE2A-4389AA9F37FB

Q34957142-F9F7674B-6D2C-4BAA-9CAD-6EE954AA835B

P275

Q34957142-F09EA380-BC52-450C-9357-A1DE9530953B

P2860

Q34957142-04583D56-D383-436D-AAF5-428F387B7BBA

Q34957142-04684B64-A288-473E-A1A1-40D10D6B4B5C

Q34957142-053106AD-F345-45DF-8B67-E148E4F0E399

Q34957142-05E1E3C4-1FDB-4ABC-809E-41508300A88A

Q34957142-06EBC0E2-738A-4F4C-AC81-D090506C95B4

Q34957142-07419194-F5FF-4524-AA24-3EED11F75962

Q34957142-0FEAD91A-7836-4E58-9B60-D5191402ECA7

Q34957142-10ADC1A5-D595-41DD-B3AB-9CA99F70054A

Q34957142-118DFB78-FDFA-4CDC-82CF-C6EBDF0DC92D

Q34957142-1250CF3F-A0D7-4719-A3F4-51DDBF3A3077

P2888

Q34957142-1700260E-C69C-4AFE-A627-B61501592BFE

P304

Q34957142-F9CAE9DD-9660-407D-9DD0-FE1583416843

P31

Q34957142-259CC988-230D-442E-98F6-078227B7EAF5

Q34957142-E92CA4E6-C228-4B00-ABEB-01E33BC70F5F

P356

Q34957142-8F441CD9-61B7-4A02-AB03-4DEEC69E5248

P478

Q34957142-71557E1D-55D4-4FF5-BC10-C68A62ABC72F

P5008

Q34957142-C7AABDB3-DC3F-4E2A-AEBA-B067C855564F

P577

Q34957142-85AE5BB9-FF8E-4E72-84A2-6EDFF7615B7E

P5875

Q34957142-5387252E-A382-4BA3-A8AD-8A7EAA6F759F

P6179

Q34957142-E2ED54D1-7541-41B8-BA94-98B62F1C6852

P698

Q34957142-9469B280-0F0C-489A-9DE2-4F4F2F34E250

P921

Q34957142-1D453E82-080C-424C-8682-465FF7992A58

Q34957142-29B5C456-8A55-4A79-AEA5-71752EA13BD2

Q34957142-55E68BB6-9E58-4894-94BE-7F552233F103

Q34957142-725E78D7-B2E5-4E30-817D-1A958AF9AD90

Q34957142-BB118997-465C-43CF-9707-6B490016E5C1

Q34957142-FCEFA360-5BE7-40D7-AC36-F4982E2C0B3A

P932

Q34957142-9962C34D-2812-4380-9CF1-A130209B9132

P356

P1433

P1476

HIV-1 accessory protein Vpr: r ...... l for therapeutic intervention

@en

P2093

Jay Rappaport

http://www.w3.org/2001/XMLSchema#string

Michael Kogan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase

A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway

The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex

Identification of NTF2, a cytosolic factor for nuclear import that interacts with nuclear pore complex protein p62

The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection

A novel receptor-mediated nuclear protein import pathway

Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.

Dominant-negative mutants of importin-beta block multiple pathways of import and export through the nuclear pore complex

Viral protein R regulates nuclear import of the HIV-1 pre-integration complex

A 41 amino acid motif in importin-alpha confers binding to importin-beta and hence transit into the nucleus

P2888

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-8-25

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51047812

http://www.w3.org/2001/XMLSchema#string

P6179

1027413182

http://www.w3.org/2001/XMLSchema#string

P698

21489275

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

P932

3090340

http://www.w3.org/2001/XMLSchema#string